Investigational Site Number 840002 — New York, New York

Investigational Site Number 840002 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840002 has participated in 2 clinical trials.

Therapeutic areas: Neoplasm Malignant, Glioblastoma, Astrocytoma, Grade IV.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840002?

Investigational Site Number 840002 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840002 conducted?

Investigational Site Number 840002 has 2 clinical trials on record. Their work covers Neoplasm Malignant, Glioblastoma, Astrocytoma, Grade IV.

Is Investigational Site Number 840002 accredited by Crixeo Health?

Investigational Site Number 840002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.